A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

Exclusion Criteria

• •On nasal examination, the presence of nasal mucosal erosion, nasal ulceration or nasal septal perforation
• •Use of any investigational drug within 30 days of the first visit
• •Any nasal surgery or sinus surgery within the previous year
• •Presence of any hypersensitivity to drugs similar to azelastine or mometasone furoate and to either sorbital or sucralose
• •Women who are pregnant or nursing
• •Women who are not using an acceptable method of birth control
• •Nasal Diseases likely to affect deposition of intranasal medication, such as sinusitis, rhinitis medicamentosa or clinically significant nasal polyposis or nasal structural abnormalities.
• •Asthma or other lung diseases such as COPD. Mild asthma symptoms may be considered after consultation with investigator.
• •Patients with Arrythmia
• •Patients with know history of alcohol and drug abuse
• •Existence of any surgical or medical condition, which in the opinion of the investigator or sponsor, might significantly alter the evaluation of the study.
• •Use of medications that could affect the study results